Strong Buy Stocks Based on Stock Market Algorithm: Returns up to 17.61% in 3 Days

Strong Buy Stocks

This forecast is part of the Top 10 Stocks Package, as one of I Know First’s systematic trading tools. The full package includes a daily prediction for a total of 20 strong buy stocks with bullish and bearish signals:

  • Top 10 stocks pick for the long position
  • Top 10 stocks pick for the short position


Package Name: Stock Forecast & S&P500 Forecast
Recommended Positions: Long
Forecast Length: 3 Days (4/16/2020 – 4/19/2020)
I Know First Average: 6.88%
Strong Buy Stocks
Strong Buy Stocks chart

The algorithm correctly predicted 9 out 10 of the suggested trades in the Stock Forecast & S&P500 Forecast Package for this 3 Days forecast. BLUE was the top performing prediction with a return of 17.61%. MLCO and PII saw outstanding returns of 10.38% and 10.06%. The Stock Forecast & S&P500 Forecast package had an overall average return of 6.88%, providing investors with a premium of 3.60% over the S&P 500’s return of 3.28%.

bluebird bio, Inc., incorporated on April 16, 1992, is a clinical-stage biotechnology company. The Company is focused on developing gene therapies for severe diseases and cancer. With its lentiviral-based gene therapy and gene editing capabilities, it has built an integrated product platform with various applications in these areas. The Company’s clinical programs in severe genetic diseases include its LentiGlobin product candidate to treat transfusion-dependent b-thalassemia (TDT) and to treat severe sickle cell disease (SCD) and its Lenti-D product candidate to treat cerebral adrenoleukodystrophy (CALD). Its programs in oncology are built upon its lentiviral gene delivery and T cell engineering, with a focus on developing T cell-based immunotherapies, including chimeric antigen receptor (CAR) and T cell receptor (TCR) T cell therapies. bb2121, its lead product candidate in oncology, is a CAR T cell product candidate for the treatment of multiple myeloma. It also has discovery research programs utilizing megaTALs/homing endonuclease gene editing technologies for use across its pipeline.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.